Apollo Hospitals Enterprise Limited vs Senores Pharmaceuticals Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Senores Pharmaceuticals Limited (SENORES) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Apollo Hospitals Enterprise Limited vs Senores Pharmaceuticals Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation22
  • Profitability22
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
51.55
13.46
P/B ratio
7.21
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹25.05

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
0.00%
17.31%
Return on capital
14.43%
14.94%
EBITDA margin
26.61%
7.94%
Net margin
19.21%

Growth

SENORES takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
162.44%
33.35%
Profit CAGR (3Y)
147.66%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹6,058 Cr
₹25,229 Cr
Revenue
₹633 Cr
₹2,003 Cr
Net profit
₹122 Cr
0.90
Debt / equity
0.37
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
Senores Pharmaceuticals Limited
  • + ["Company has delivered good profit growth of 161.2% CAGR over last 5 years", "Company has delivered good sales growth of 139.7% CAGR over last 5 years"]
  • − ["Stock is trading at 6.50 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
Apollo Hospitals Enterprise Limited full analysis Senores Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.